GlassScriptPhysician profile
Bernard J Vittone
NPI 1558575290
$2,610.36
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,200 · 2020: $576 · 2021: $667 · 2022: $167.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $671.37 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $548.38 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $430.86 | 2019-2022 | |
| Bausch Health US, LLC | $210.61 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.67 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $176.88 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $131.86 | 2020-2021 | |
| Shire North American Group INC | $103.19 | 2019 | |
| Adlon Therapeutics L.P. | $67.66 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $32.55 | 2019 | |
| Eisai INC. | $20.00 | 2021 | |
| Avanir Pharmaceuticals, INC. | $17.79 | 2019 | |
| Allergan, INC. | $12.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Vittone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.